Drug Master Files for: NANDROLONE DECANOATE
✉ Email this page to a colleague
NANDROLONE DECANOATE Drug Master Files
| DMF No. | Status | Type | Submission Date | Holder | Subject |
|---|---|---|---|---|---|
| 21762 | A | II | 7/3/2008 | ASPEN OSS BV | NANDROLONE DECANOATE |
| 2251 | I | II | 3/18/1974 | ORGANON INC | NORANDROS TENEDIONE (NANDROLONE) |
| 2399 | I | II | 2/11/1975 | ROUSSELL UCLAF | 19-NOR-ANDROSTENEDIONE (NANDROLONE) |
| 24883 | I | II | 11/21/2011 | RELIANCE LIFE SCIENCES PVT LTD | NANDROLONE DECANOATE USP |
| 3225 | I | II | 5/25/1978 | ORMA ISTITUDO TERAPEUTICO | NANDROLONE PHENYLPROPIONATE |
| >DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information
